SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
8440099
Source:
http://linkedlifedata.com/resource/pubmed/id/8440099
Search
Subject
(
64
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003250
,
umls-concept:C0027540
,
umls-concept:C0030705
,
umls-concept:C0079189
,
umls-concept:C0242966
,
umls-concept:C0243026
,
umls-concept:C0441889
,
umls-concept:C1257890
,
umls-concept:C1521761
,
umls-concept:C2603343
pubmed:issue
3
pubmed:dateCreated
1993-3-31
pubmed:abstractText
To determine the safety, pharmacokinetics, and activity of an anti-tumor necrosis factor (TNF)-alpha monoclonal antibody in severe sepsis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8440099-7802809
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8440099-8440095
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0355501
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines
,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6
,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0090-3493
pubmed:author
pubmed-author:DhainautJ FJF
,
pubmed-author:FisherC JCJJr
,
pubmed-author:HarrisS JSJ
,
pubmed-author:NightingalePP
,
pubmed-author:OpalS MSM
,
pubmed-author:PanacekE AEA
,
pubmed-author:ScheinR MRM
,
pubmed-author:StephensSS
,
pubmed-author:VincentJ LJL
,
pubmed-author:ZimmermanJ LJL
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
318-27
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:8440099-Antibodies, Monoclonal
,
pubmed-meshheading:8440099-Bacteria
,
pubmed-meshheading:8440099-Bacterial Physiological Phenomena
,
pubmed-meshheading:8440099-Cytokines
,
pubmed-meshheading:8440099-Female
,
pubmed-meshheading:8440099-Humans
,
pubmed-meshheading:8440099-Infection
,
pubmed-meshheading:8440099-Interleukin-6
,
pubmed-meshheading:8440099-Male
,
pubmed-meshheading:8440099-Middle Aged
,
pubmed-meshheading:8440099-Prospective Studies
,
pubmed-meshheading:8440099-Shock, Septic
,
pubmed-meshheading:8440099-Tumor Necrosis Factor-alpha
pubmed:year
1993
pubmed:articleTitle
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group.
pubmed:affiliation
Department of Pulmonary, Cleveland Clinic Foundation 44195.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Controlled Clinical Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase II